Micropolis Faces Delisting Risk After Missing 2025 20-F Filing Deadline
Micropolis failed to file its 2025 annual 20-F report by the May 15, 2026 deadline and received a NYSE American notice of non-compliance. The company faces an initial cure period until November 15, 2026 and could face delisting procedures if it does not file within that window.
1. Noncompliance Notification
On May 18, 2026 Micropolis received a notice from NYSE American stating it failed to file its annual Form 20-F for the fiscal year ended December 31, 2025 by the May 15 deadline, triggering non-compliance under Section 1007 of the NYSE American Company Guide.
2. Cure Period and Potential Delisting
NYSE American has granted an initial six-month cure period until November 15, 2026 to file the delayed 2025 Form 20-F. Failure to meet this deadline may lead to an additional six-month extension through May 15, 2027 or commencement of suspension and delisting procedures under Section 1010.
3. Audit-Related Filing Delay
The company attributed the filing delay to ongoing audit-related matters requiring additional time to resolve, as disclosed in its April 29 Form 12b-25, and is working with auditors and advisors to complete the financial statements for the fiscal year ended December 31, 2025.
4. Ongoing Listing Status
Despite the delinquency notice, Micropolis’s ordinary shares will continue trading on NYSE American during the cure period, subject to compliance with all other listing requirements.